Steven R. Ph.D. Gullans is a director of iSpecimen Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
iSpecimen Inc.
17 May 23
5
iSpecimen Inc.
10 Feb 23
4
iSpecimen Inc.
13 Jan 23
5
iSpecimen Inc.
14 Feb 22
3
iSpecimen Inc.
17 Jun 21
4
NeuroBo Pharmaceuticals, Inc.
15 Jan 20
4
Gemphire Therapeutics Inc.
26 Jul 19
4
Gemphire Therapeutics Inc.
24 May 18
4
Gemphire Therapeutics Inc.
3 May 18
4
Gemphire Therapeutics Inc.
12 Feb 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 23 | ISPC iSpecimen | Option Common Stock | Grant | Acquire A | No | No | 1.41 | 10,000 | 14.10 k | 23,525 |
1 Jan 23 | ISPC iSpecimen | Common Stock | Grant | Acquire A | No | No | 0 | 125 | 0.00 | 3,250 |
1 Oct 22 | ISPC iSpecimen | Common Stock | Grant | Acquire A | No | No | 0 | 625 | 0.00 | 3,125 |